[go: up one dir, main page]

Konturek et al., 1972 - Google Patents

Mechanism of the Inhibitory Action of Endogenous Cholecystokinin and Caerulein on Pentagastrin—Induced Gastric Secretion

Konturek et al., 1972

Document ID
15809221185406796579
Author
Konturek S
Tasler J
Obtulowicz W
Publication year
Publication venue
Scandinavian Journal of Gastroenterology

External Links

Snippet

In dogs with vagally innervated gastric pouches (PP), gastric fistulas, and pancreatic fistulas, half maximal response to pentagastrin has been obtained. Caerulein given intravenously in doses ranging from 60 to 500 ng/kg-hr caused a dose-related inhibition of PP response to …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]

Similar Documents

Publication Publication Date Title
Konturek et al. Effects of epidermal growth factor on gastrointestinal secretions
US5124314A (en) Pharmaceutical compositions containing amylin
KoNTUREK et al. Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.
Johnson et al. Secretin: the enterogastrone released by acid in the duodenum
Erspamer et al. Evidence of cholecystokinin release by bombesin in the dog
US5175145A (en) Treatment of diabetes mellitus with amylin agonists
Gershberg et al. The role of epinephrine in the secretion of the adrenal cortex
HK1000934B (en) Use of amylin or cgrp for the treatment of diabetes mellitus
Stening et al. Effect of cholecystokinin and caerulein on gastrin-and histamine-evoked gastric secretion
Bodgen et al. Response of human lung tumor xenografts to treatment with a somatostatin analogue (Somatuline)
Konturek et al. Gastroduodenal alkaline response to acid and taurocholate in conscious dogs
Cherrington et al. Arginine infusion in dogs: model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels
Figg et al. A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone‐refractory prostate cancer
Nylander et al. Vagal influence on gastroduodenal HCO3-secretion in the cat in vivo
Pozza et al. Insulin secretion following carbutamide injections in normal dogs.
Konturek et al. Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog
Nakajima et al. Influences of duodenal acidification on acid and pepsin secretion of the stomach in dogs
Konturek et al. Localization of cholecystokinin release in intestine of the dog
Konturek et al. Methionine-enkephalin stimulates gastric secretion and gastric mucosal blood flow
Brown-Grant et al. The effect of exogenous and endogenous adrenaline on the uptake of radio-iodine by the thyroid gland of the rabbit
Konturek et al. Mechanism of the Inhibitory Action of Endogenous Cholecystokinin and Caerulein on Pentagastrin—Induced Gastric Secretion
Bolman III et al. Stimulation of gastrin secretion in the pig by parathyroid hormone and its inhibition by thyrocalcitonin
Pappas et al. Corticotropin-releasing factor inhibits gastric emptying in dogs: studies on its mechanism of action
Moreau et al. Comparison of Somatuline (BIM‐23014) and somatostatin on endocrine and exocrine activities in the rat
Pettit et al. An analysis of the contribution of the endocrine pancreas to the kalemotropic actions of catecholamines